Behavioral Treatment for Cocaine Dependent Women
2 other identifiers
interventional
145
1 country
2
Brief Summary
To compare the efficacy of Community Reinforcement Approach (CRA) and 12-Step Facilitation (TSF) counseling and of voucher based reward therapy (VBRT) and a yoked, non-contingent voucher control (VC) for the treatment of cocaine dependent pregnant women or women with young children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Dec 1994
Longer than P75 for phase_2
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 1994
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2002
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2002
CompletedFirst Submitted
Initial submission to the registry
June 3, 2009
CompletedFirst Posted
Study publicly available on registry
June 5, 2009
CompletedMarch 31, 2020
June 1, 2009
7.3 years
June 3, 2009
March 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cocaine abstinence
24 weeks
Secondary Outcomes (1)
Reduced HIV risk behavior
24 weeks
Study Arms (4)
CRA + CM
ACTIVE COMPARATORCommunity Reinforcement Approach (CRA) combined with Contingency Management (CM)
TSF + CM
ACTIVE COMPARATORTwelve-Step Facilitation (TSF) combined with Contingency Management (CM)
CRA + VC
ACTIVE COMPARATORCommunity Reinforcement Approach (CRA) combined with Voucher Control (VC)
TSF + VC
ACTIVE COMPARATORTwelve-Step Facilitation (TSF) combined with Voucher Control (VC)
Interventions
Eligibility Criteria
You may qualify if:
- Pregnant women meeting DSM IV criteria for cocaine dependence
- Women meeting DSM IV criteria for cocaine dependence with custody of a young child
You may not qualify if:
- Opioid dependence
- Psychosis
- Severe depression
- Current treatment with any anti-depressant or anti-psychotic medication
- Medical instability
- Inability to understand or read English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (2)
The APT Foundation, Inc. MRU
New Haven, Connecticut, 06519, United States
Yale University School of Medicine
New Haven, Connecticut, 06519, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard S. Schottenfeld, M.D.
Yale University
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 3, 2009
First Posted
June 5, 2009
Study Start
December 1, 1994
Primary Completion
March 1, 2002
Study Completion
March 1, 2002
Last Updated
March 31, 2020
Record last verified: 2009-06